• The development of drugs and companion diagnostics requires the collection of rigorous and reliable chemical, pharmaceutical, and biological data. • Candidate gene association studies can identify ...
The concept of regulatory science is not a new one. The FDA Science Board’s 2007 Science and Mission at Risk report (FDA Science Board, 2007) describes regulatory science as a science-based ...
The authors explore and define common industry approaches and practices when applying GMPs in early development. The International Consortium on Innovation and Quality in Pharmaceutical Development ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果